{{Rsnum
|rsid=3884558
|Chromosome=15
|position=61410580
|Orientation=plus
|GMAF=0.2984
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 19.5 | 80.5
| HCB | 38.0 | 48.2 | 13.9
| JPT | 45.1 | 42.5 | 12.4
| YRI | 8.2 | 27.9 | 63.9
| ASW | 3.6 | 27.3 | 69.1
| CHB | 38.0 | 48.2 | 13.9
| CHD | 36.7 | 52.3 | 11.0
| GIH | 1.0 | 33.0 | 66.0
| LWK | 2.8 | 43.0 | 54.2
| MEX | 8.6 | 67.2 | 24.1
| MKK | 12.0 | 40.0 | 48.0
| TSI | 2.0 | 15.7 | 82.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23319801
  |Trait=Breast cancer (prognosis)
  |Title=Identification of Inherited Genetic Variations Influencing Prognosis in Early-Onset Breast Cancer.
  |RiskAllele=
  |Pval=4E-6
  |OR=1.46
  |ORtxt=[1.24-1.72]
  |OA=1
}}

{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=5E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}